We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

193 hedge funds and large institutions have $581M invested in Sage Therapeutics in 2024 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 76 increasing their positions, 54 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

363% more call options, than puts

Call options by funds: $10.1M | Put options by funds: $2.18M

41% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 54

5% less funds holding

Funds holding: 204 → 193 (-11)

8.37% less ownership

Funds ownership: 97.3% → 88.92% (-8.4%)

20% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 40

47% less capital invested

Capital invested by funds: $1.1B → $581M (-$516M)

Holders
193
Holders Change
-11
Holders Change %
-5.39%
% of All Funds
2.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
76
Reduced
54
Closed
40
Calls
$10.1M
Puts
$2.18M
Net Calls
+$7.92M
Net Calls Change
+$5.82M

Top Buyers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$11.1M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$8.59M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$8.52M
4
Invesco
Invesco
Georgia
+$7.38M
5
Renaissance Technologies
Renaissance Technologies
New York
+$6.64M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$60.4M
2
State Street
State Street
Massachusetts
-$25.9M
3
Deutsche Bank
Deutsche Bank
Germany
-$12.9M
4
SC
Samlyn Capital
New York
-$11.1M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
VEA
101
Virtus ETF Advisers
New York
$311K +$137K +10,674 +59%
EAM
102
Erste Asset Management
Austria
$305K – – –
Deutsche Bank
103
Deutsche Bank
Germany
$292K -$12.9M -1,003,592 -97%
CC
104
Corton Capital
Ontario, Canada
$291K +$75.7K +5,909 +28%
FT
105
Fiduciary Trust
Massachusetts
$286K – – –
Man Group
106
Man Group
United Kingdom
$281K +$332K +25,903 New
Janus Henderson Group
107
Janus Henderson Group
United Kingdom
$281K -$3.41K -266 -1%
Wells Fargo
108
Wells Fargo
California
$268K +$94.6K +7,380 +43%
Prudential Financial
109
Prudential Financial
New Jersey
$256K +$96K +7,495 +47%
PA
110
Profund Advisors
Maryland
$249K -$482K -37,624 -62%
DFCM
111
Dark Forest Capital Management
Puerto Rico
$242K +$285K +22,245 New
ET
112
Entropy Technologies
New York
$240K +$37.2K +2,900 +15%
Royal Bank of Canada
113
Royal Bank of Canada
Ontario, Canada
$240K +$54.7K +4,272 +24%
YIH
114
Y-Intercept (HK)
Hong Kong
$240K +$283K +22,094 New
PAS
115
Point72 Asia (Singapore)
Singapore
$237K +$274K +21,411 +5,421%
DekaBank Deutsche Girozentrale
116
DekaBank Deutsche Girozentrale
Germany
$236K – – –
New York State Common Retirement Fund
117
New York State Common Retirement Fund
New York
$235K -$8.16K -637 -3%
PCM
118
Prelude Capital Management
New York
$213K +$18.5K +1,440 +8%
VOYA Investment Management
119
VOYA Investment Management
Georgia
$196K +$7.57K +591 +3%
PI
120
Pennant Investors
New Jersey
$190K – – –
VA
121
Vident Advisory
Georgia
$179K +$212K +16,528 New
SG Americas Securities
122
SG Americas Securities
New York
$177K +$209K +16,278 New
AI
123
AdvisorShares Investments
Maryland
$177K +$24.6K +1,918 +14%
Stifel Financial
124
Stifel Financial
Missouri
$168K +$20K +1,564 +11%
State Board of Administration of Florida Retirement System
125
State Board of Administration of Florida Retirement System
Florida
$165K -$19K -1,480 -9%
3 4
5
6 7

SAGE Hedge Fund Activity: Q2 2024 in Review

193 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q2 2024, worth a combined $581M — down 47% from $1.1B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of SAGE and 32 opened new positions — a net loss of 8 holders — while 54 trimmed existing stakes and 76 added.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $11.1M. The largest seller was Wellington Management Group, cutting an estimated $60.4M.

  • 193 institutional investors held Sage Therapeutics (SAGE) as of Q2 2024, down from 204 in Q1 2024.
  • Funds reported $581M of Sage Therapeutics stock for Q2 2024, down 47% quarter-over-quarter.
  • 32 funds opened new Sage Therapeutics positions in Q2 2024 and 40 closed out, a net change of -8 holders.
  • The largest Sage Therapeutics buyer in Q2 2024 was Jacobs Levy Equity Management, an estimated $11.1M added.
  • The largest Sage Therapeutics seller in Q2 2024 was Wellington Management Group, an estimated $60.4M sold.

Based on aggregated 13F filings for Q2 2024.